arrow
Kenji Shibuya 封面图

Kenji Shibuya

tokyo foundation for policy research
H指数:104
被引数:23.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to: Evidence of widespread sequencing errors in global avian influenza study

回复:全球禽流感研究中广泛测序错误证据

2026-11-020
OAAI
Author Correction: Surveillance of avian influenza through bird guano in remote regions of the global south to uncover transmission dynamics

作者更正:通过全球南方偏远地区的鸟类粪便监测禽流感以揭示传播动态

2026-10-010
OAAI
Japan's health system toward 2040: structural challenges and a renewed social contract

日本健康系统展望2040:结构性挑战与新的社会契约

2026-07-011
PRE
Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy

日本在西太平洋地区的全球卫生参与:诊断结构性惯性与人类安全外交框架

2026-07-011
PRE
Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections

鼻内噬菌体疗法克服了肺铜绿假单胞菌感染中的抗体中和挑战

2025-10-180
PRE
Tapeworm infection incidence in rural Japan points to a common environmental source of infection

日本农村地区带绦虫感染的发生率表明感染源为共同的环境因素。

2025-10-010
OA
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection

COVID-19 mRNA疫苗接种后测量的纵向抗体滴度可识别后续感染风险人群

2025-09-170
PRE
Global participatory wastewater surveillance to understand mpox clade diversity in war and conflict-affected countries

全球参与式废水监测,以了解战乱和冲突影响国家的猴痘病毒分支多样性

2025-07-012
PRE
Surveillance of avian influenza through bird guano in remote regions of the global south to uncover transmission dynamics

通过全球南方偏远地区鸟类粪便监测禽流感,以揭示传播动态

2025-05-270
OAAI
tesG expression as a potential clinical biomarker for chronic Pseudomonas aeruginosa pulmonary biofilm infections

tesG表达作为慢性铜绿假单胞菌肺部生物膜感染的潜在临床生物标志物

2025-03-310
OA
Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south

在全球南部使用废弃的避孕套进行基于社区的mpox和性传播疾病监测

2024-10-010
PRE
Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1

SARS-CoV-2变体BA.2.86和JN.1中的粪便脱落增加

2024-06-017
OAAI
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

1990至2021 204个国家和地区以及811个地方的371疾病和伤害的全球发病率,患病率,残疾寿命 (YLDs),残疾调整寿命 (DALYs) 和健康预期寿命 (HALE): 全球疾病负担研究2021的系统分析

LANCET
IF88.5
2024-05-01285
OAAI
Wastewater-based epidemiological surveillance of SARS-CoV-2 new variants BA.2.86 and offspring JN.1 in South and Southeast Asia

南亚和东南亚SARS-CoV-2新变种BA.2.86和后代JN.1的基于废水的流行病学监测

2024-03-043
PRE